| Hepatic glycosphingolipid deficiency and liver function in mice. | |
| | |
MedLine Citation:
|
PMID: 20432257 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Recent studies have reported that glycosphingolipids (GSLs) might be involved in obesity-induced insulin resistance. Those reports suggested that inhibition of GSL biosynthesis in animals ameliorated insulin resistance accompanied by improved glycemic control and decreased liver steatosis in obese mice. In addition, pharmacologic GSL depletion altered hepatic secretory function. In those studies, ubiquitously acting inhibitors for GSL biosynthesis have been used to inhibit the enzyme Ugcg (UDP-glucose:ceramide glucosyltransferase), catalyzing the first step of the glucosylceramide-based GSL-synthesis pathway. In the present study a genetic approach for selective GSL deletion in hepatocytes was chosen to achieve complete inhibition of GSL synthesis and to avoid possible adverse effects caused by Ugcg inhibitors. Using the Cre/loxP system under control of the albumin promoter, GSL biosynthesis in hepatocytes and their release into the plasma could be effectively blocked. Deletion of GSL in hepatocytes did not change the quantity of bile excretion through the biliary duct. Total bile salt content in bile, feces, and plasma from mutant mice showed no difference as compared to control animals. Cholesterol concentration in liver, bile, feces, and plasma samples remained unaffected. Lipoprotein concentrations in plasma samples in mutant animals reached similar levels as in their control littermates. No alteration in glucose tolerance after intraperitoneal application of glucose and insulin appeared in mutant animals. A preventive effect of GSL deficiency on development of liver steatosis after a high-fat diet was not observed. CONCLUSION: The data suggest that GSL in hepatocytes are not essential for sterol, glucose, or lipoprotein metabolism and do not prevent high-fat diet-induced liver steatosis, indicating that Ugcg inhibitors exert their effect on hepatocytes either independently of GSL or mediated by other (liver) cell types. |
| | |
Authors:
|
Richard Jennemann; Ulrike Rothermel; Shijun Wang; Roger Sandhoff; Sylvia Kaden; Ruud Out; Theo J van Berkel; Johannes M Aerts; Karen Ghauharali; Carsten Sticht; Hermann-Josef Gr?ne |
Related Documents
:
|
12114517 - Leptin promotes biliary cholesterol elimination during weight loss in ob/ob mice by reg... 7956607 - Effects of octreotide on biliary lipid composition and occurrence of cholesterol crysta... 22504637 - The effects of dietary obesity on protein expressions of insulin signaling pathway in r... 22529197 - Impact of short term high fat feeding and insulin stimulated fgf21 levels in subjects w... 20687227 - Chemoprevention of prostate cancer with lycopene in the tramp model. 1804467 - Lipid and lipoprotein levels in adults receiving liposyn ii. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Hepatology (Baltimore, Md.) Volume: 51 ISSN: 1527-3350 ISO Abbreviation: Hepatology Publication Date: 2010 May |
Date Detail:
|
Created Date: 2010-04-30 Completed Date: 2010-05-14 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8302946 Medline TA: Hepatology Country: United States |
Other Details:
|
Languages: eng Pagination: 1799-809 Citation Subset: IM |
Affiliation:
|
Cellular and Molecular Pathology, German Cancer Research Center, Heidelberg, Germany. r.jennemann@dkfz.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animal Nutritional Physiological Phenomena Animals Bile / physiology Ceramides / metabolism Cholesterol / metabolism Gene Deletion Glucosyltransferases / antagonists & inhibitors, metabolism* Glycosphingolipids / biosynthesis, deficiency* Hepatocytes / metabolism Insulin Resistance / physiology* Lipids / blood Liver / metabolism*, ultrastructure Mice Mice, Transgenic Phospholipids / metabolism Sphingomyelins / metabolism |
| Chemical | |
Reg. No./Substance:
|
0/Ceramides; 0/Glycosphingolipids; 0/Lipids; 0/Phospholipids; 0/Sphingomyelins; 57-88-5/Cholesterol; EC 2.4.1.-/Glucosyltransferases; EC 2.4.1.80/ceramide glucosyltransferase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: MicroRNAs control hepatocyte proliferation during liver regeneration.
Next Document: Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes.